Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 3
1988 2
1989 1
1990 1
1994 1
1999 1
2005 1
2007 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis.
Kaufman RH, Henzl MR, Brown D Jr, Horner DS, Krauss RH, Mehlisch DR, Moore DE, Prentice RL. Kaufman RH, et al. J Reprod Med. 1989 Jul;34(7):479-83. J Reprod Med. 1989. PMID: 2671362 Clinical Trial.
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients were Candida negative; 80% of the butoconazole-treated patients and 82% of the miconazole-treated patients were considered clinically cu …
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients wer …
Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.
Brown D, Henzl MR, Kaufman RH. Brown D, et al. J Reprod Med. 1999 Nov;44(11):933-8. J Reprod Med. 1999. PMID: 10589403 Clinical Trial.
OBJECTIVE: To compare the safety and efficacy of a single vaginal dose of a butoconazole nitrate 2% bioadhesive, sustained-release cream* (butoconazole 1-BSR) with a seven-day schedule of miconazole nitrate vaginal cream 2% (miconazole 7). ...A total of 205 patients …
OBJECTIVE: To compare the safety and efficacy of a single vaginal dose of a butoconazole nitrate 2% bioadhesive, sustained-release cr …
A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis.
Ruf H, Vitse M. Ruf H, et al. J Int Med Res. 1990 Sep-Oct;18(5):389-99. doi: 10.1177/030006059001800507. J Int Med Res. 1990. PMID: 2257961 Clinical Trial.
In a randomized, single-blind, parallel study the safety and efficacy of 2% butoconazole nitrate cream used for 3 days were compared with those of 1% econazole nitrate cream used for 7 days at night in patients with vulvovaginal candidiasis. ...Although both drugs were saf …
In a randomized, single-blind, parallel study the safety and efficacy of 2% butoconazole nitrate cream used for 3 days were compared …
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS, Skokos CK. Seidman LS, et al. Infect Dis Obstet Gynecol. 2005 Dec;13(4):197-206. doi: 10.1080/10647440500240615. Infect Dis Obstet Gynecol. 2005. PMID: 16338779 Free PMC article. Clinical Trial.

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazole patients (p < 0.001). The time at which 75% of patients experienced first relief of symptoms was 24.5 h versus 46.3 h for butoconaz

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazo …
Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis.
Droegemueller W, Adamson DG, Brown D, Cibley L, Fleury F, LePage ME, Henzl MR. Droegemueller W, et al. Obstet Gynecol. 1984 Oct;64(4):530-4. Obstet Gynecol. 1984. PMID: 6384848 Clinical Trial.
A multicenter clinical trial of 274 patients compared the efficacy and safety of a new vaginal antifungal compound, butoconazole nitrate cream 2% (butoconazole), to clotrimazole vaginal tablets 200 mg/day (clotrimazole). ...Complete absence of the entrance signs and …
A multicenter clinical trial of 274 patients compared the efficacy and safety of a new vaginal antifungal compound, butoconazole nitr …
Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream.
Hajman AJ. Hajman AJ. J Int Med Res. 1988 Sep-Oct;16(5):367-75. doi: 10.1177/030006058801600506. J Int Med Res. 1988. PMID: 3197914 Clinical Trial.
Both treatments improved the clinical signs and symptoms of candidosis. More butoconazole nitrate-treated patients (53.3%) had a 'very good' clinical response to treatment than clotrimazole-treated patients (38.7%). ...No adverse experiences were associated with either tre …
Both treatments improved the clinical signs and symptoms of candidosis. More butoconazole nitrate-treated patients (53.3%) had a 'ver …
Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation.
Weinstein L, Henzel MR, Tsina IW. Weinstein L, et al. Clin Ther. 1994 Nov-Dec;16(6):930-4. Clin Ther. 1994. PMID: 7697689 Clinical Trial.
The purpose of this study was to establish the length of time that butoconazole nitrate 2% standard cream and sustained-release cream could be detected in the vagina after a single administration of 5 g of cream that contained 100 mg of butoconazole. ...Participants …
The purpose of this study was to establish the length of time that butoconazole nitrate 2% standard cream and sustained-release cream …
A new vaginal antifungal agent--butoconazole nitrate.
Jacobson JB, Hajman AJ, Wiese J, Gandrup P, Forsström S. Jacobson JB, et al. Acta Obstet Gynecol Scand. 1985;64(3):241-4. doi: 10.3109/00016348509155121. Acta Obstet Gynecol Scand. 1985. PMID: 3893024 Clinical Trial.
The continuously increasing incidence of vulvovaginal candidiasis necessitated a search for novel therapeutic modalities. Butoconazole nitrate (BN) a new imidazole, has been singled out for clinical studies since, in experimental vaginal candidiasis, it proved more effecti …
The continuously increasing incidence of vulvovaginal candidiasis necessitated a search for novel therapeutic modalities. Butoconazole
Butoconazole and miconazole in treating vaginal candidiasis.
Bradbeer CS, Mayhew SR, Barlow D. Bradbeer CS, et al. Genitourin Med. 1985 Aug;61(4):270-2. doi: 10.1136/sti.61.4.270. Genitourin Med. 1985. PMID: 3894216 Free PMC article. Clinical Trial.
In a single blind trial, a three day course of butoconazole nitrate cream was compared with a seven day course of miconazole nitrate cream, both applied intravaginally, in treating vaginal candidiasis. They were equally effective. The cure rate for patients treated with …
In a single blind trial, a three day course of butoconazole nitrate cream was compared with a seven day course of miconazole nitrate …
Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis.
Adamson GD, Brown D Jr, Standard JV, Henzl MR. Adamson GD, et al. J Reprod Med. 1986 Feb;31(2):131-2. J Reprod Med. 1986. PMID: 3514908 Clinical Trial.
Butoconazole is a new imidazole, effective as therapy for vulvovaginal candidiasis for women who prefer solid-type vaginal preparations. The efficacy of three-day administration of butoconazole vaginal suppositories, 100 mg/day, was compared to that of clotrimazole
Butoconazole is a new imidazole, effective as therapy for vulvovaginal candidiasis for women who prefer solid-type vaginal preparatio
14 results